Clin Transl Sci:过敏性鼻炎的敏感基因鉴定

2019-12-17 AlexYang MedSci原创

作为一种世界范围内极度流行的疾病,过敏性鼻炎(AR)是一种鼻粘膜慢性炎症疾病。最近,有研究人员为了鉴定与AR易感基因相关的更加精细的分子机制,研究人员调查了AR患者中的差异表达基因(DEGs)。研究人员使用DEG表达和GSE19187临床数据库进行了加权基因共表达分析(WGCNA)。当与AR相关的模块筛选过后,研究人员将模块中的基因用于基因本体和KEGG途径富集分析,而在KEGG途径富集的基因认为

作为一种世界范围内极度流行的疾病,过敏性鼻炎(AR)是一种鼻粘膜慢性炎症疾病。最近,有研究人员为了鉴定与AR易感基因相关的更加精细的分子机制,研究人员调查了AR患者中的差异表达基因(DEGs)。

研究人员使用DEG表达和GSE19187临床数据库进行了加权基因共表达分析(WGCNA)。当与AR相关的模块筛选过后,研究人员将模块中的基因用于基因本体和KEGG途径富集分析,而在KEGG途径富集的基因认为是相关途径基因。AR患者中的DEGs随后从GSE19187筛选出来,其中的敏感基因在与过敏原挑战有关的GSE19187数据库中进行鉴定。研究人员将2类基因与途径基因进行了比较从而来筛选AR易感基因。特征曲线(ROC)用于评估易感基因在区分AR状态中的能力。基于GSE19187数据库中的WGCNA,研究人员共鉴定10个共表达网络模块。相关性分析阐释了黄色模块与AR疾病状态呈现正相关关系。在黄色模块富集的途径中,研究人员总共鉴定了89个基因。其中4个基因(CST1、SH2D1B、DPP4和SLC5A5)在AR中表达上调并对过敏原挑战敏感,且在ROC曲线中得到了进一步的验证。

最后,研究人员指出,CST1、SH2D1B、DPP4和SLC5A5是AR的易感性基因。

原始出处:

Xue K, Yang J, Zhao Y et al. Identification of Susceptibility Genes to Allergic Rhinitis by Gene Expression Data Sets. Clin Transl Sci. 03 Dec 2019

本文系williamhill asia 医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2047199, encodeId=50f2204e1996a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Apr 07 07:30:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657280, encodeId=248c165e28058, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Thu Feb 27 15:30:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928593, encodeId=85a21928593c3, content=<a href='/topic/show?id=9d375e53252' target=_blank style='color:#2F92EE;'>#敏感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57532, encryptionId=9d375e53252, topicName=敏感基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 03 00:30:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067488, encodeId=25dc206e48826, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Oct 23 03:30:00 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377098, encodeId=71c33e709820, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Wed Dec 18 04:17:33 CST 2019, time=2019-12-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2047199, encodeId=50f2204e1996a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Apr 07 07:30:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657280, encodeId=248c165e28058, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Thu Feb 27 15:30:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928593, encodeId=85a21928593c3, content=<a href='/topic/show?id=9d375e53252' target=_blank style='color:#2F92EE;'>#敏感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57532, encryptionId=9d375e53252, topicName=敏感基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 03 00:30:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067488, encodeId=25dc206e48826, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Oct 23 03:30:00 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377098, encodeId=71c33e709820, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Wed Dec 18 04:17:33 CST 2019, time=2019-12-18, status=1, ipAttribution=)]
    2020-02-27 bsmagic9140
  3. [GetPortalCommentsPageByObjectIdResponse(id=2047199, encodeId=50f2204e1996a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Apr 07 07:30:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657280, encodeId=248c165e28058, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Thu Feb 27 15:30:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928593, encodeId=85a21928593c3, content=<a href='/topic/show?id=9d375e53252' target=_blank style='color:#2F92EE;'>#敏感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57532, encryptionId=9d375e53252, topicName=敏感基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 03 00:30:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067488, encodeId=25dc206e48826, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Oct 23 03:30:00 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377098, encodeId=71c33e709820, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Wed Dec 18 04:17:33 CST 2019, time=2019-12-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2047199, encodeId=50f2204e1996a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Apr 07 07:30:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657280, encodeId=248c165e28058, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Thu Feb 27 15:30:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928593, encodeId=85a21928593c3, content=<a href='/topic/show?id=9d375e53252' target=_blank style='color:#2F92EE;'>#敏感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57532, encryptionId=9d375e53252, topicName=敏感基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 03 00:30:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067488, encodeId=25dc206e48826, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Oct 23 03:30:00 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377098, encodeId=71c33e709820, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Wed Dec 18 04:17:33 CST 2019, time=2019-12-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2047199, encodeId=50f2204e1996a, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Tue Apr 07 07:30:00 CST 2020, time=2020-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1657280, encodeId=248c165e28058, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Thu Feb 27 15:30:00 CST 2020, time=2020-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928593, encodeId=85a21928593c3, content=<a href='/topic/show?id=9d375e53252' target=_blank style='color:#2F92EE;'>#敏感基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57532, encryptionId=9d375e53252, topicName=敏感基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8346212, createdName=respect, createdTime=Sun May 03 00:30:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067488, encodeId=25dc206e48826, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Oct 23 03:30:00 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377098, encodeId=71c33e709820, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00501987275, createdName=130****4638, createdTime=Wed Dec 18 04:17:33 CST 2019, time=2019-12-18, status=1, ipAttribution=)]
    2019-12-18 130****4638

    学习了,谢谢分享

    0

相关威廉亚洲官网

Nutrients:饮食中的ω-3脂肪酸能够抑制过敏性鼻炎

代谢和生物活性脂质调节因子的产生是饮食中的ω-3脂肪酸在调控过敏性炎症中发挥有益作用的关键过程。最近,有研究人员发现食用包含高水平亚麻酸(ALA)的亚麻籽油能够抑制过敏性鼻炎,具体机制是通过嗜酸性产生15-羟基二十碳五烯酸(15-HEPE)来实现抑制效果的,15-HEPE是一种二十碳五烯酸(EPA)代谢产物。在发展为过敏性鼻炎且嗜酸性细胞数据增加时,脂肪体分析阐释了15-HEPE在亚麻籽油喂食的小

Eur Respir J:生命早期暴露于空气污染与儿童哮喘、过敏性鼻炎和湿疹的发生率

由此可见,暴露于氧化性空气污染物(O3和NO2)而不是PM2.5与儿童患哮喘和湿疹的风险增加相关。这表明改善空气质量可能有助于预防儿童期和青春期的哮喘和其他过敏性疾病。

Life Sci:Tet2下调与过敏性鼻炎调控T细胞的Foxp3 TSDR超甲基化相关

Tet蛋白是5-甲基胞嘧啶氧化酶,并且对DNA甲基化和基因表达具有深刻的影响。最近,有研究人员调查了过敏性鼻炎(AR)调控T细胞(Treg)中Tet2的作用以及与Foxp3 DNA甲基化的相关性情况。研究人员利用流式细胞仪对AR患者的外周血淋巴细胞和OVA诱导小鼠的脾淋巴细胞进行了分离。研究人员发现,与对照相比,来源于AR患者的OVA诱导的小鼠的Treg细胞数目减少,Foxp3 mRNA和蛋白表达

Int J Biometeorol:PM2.5与过敏性鼻炎日门诊量相关性研究

关于颗粒性物质PM2.5与过敏性鼻炎(AR)患者就诊数之间的相关性证据有限,尤其是在空气污染极度严重的国家中。最近,有研究人员阐释了中国北京居民中,PM2.5与AR日门诊量之间的相关性。研究总共包括了229685次AR就诊。在2010年1月1日到2012年6月30日之间每天的PM2.5浓度均值为99.5 (75.3) μg/m3。研究人员发现,PM2.5每增加10μg/m3,AR患者的就诊数量就会

BMC Pediatr:儿科中特异性疾病与贫血相关性研究

特应性疾病,比如过敏性皮肤炎、过敏性鼻炎和哮喘均是儿科患者中常见的炎症疾病。最近,有研究人员调查了儿科患者中是否这些特应性炎症疾病与贫血相关。研究是一个代表性的研究,数据来源于2016年韩国HIRA儿科数据库资料。研究总共包括了846718名儿科患者。其中,19594名(2.31%)诊断为缺铁性贫血(IDA)。包含协变量的逻辑回归分析阐释了特应性疾病与IDA之间存在相关性。其中,过敏性皮肤炎中ID

Indian J Otolaryngol Head Neck Surg:医生对过敏性鼻炎和治疗的看法

尽管过敏性鼻炎(AR)具有较高的患病率且对生活质量影响较大,但是该疾病仍旧是治疗不足。更多的是,AR与上呼吸道感染(URTI)之间的关系很少有探索。最近,有研究人员评估了医生对AR和RUTI的认识以及治疗实践情况。研究基于调查问卷,共电话访问了300名医生,其中会诊医师(CP): 33%,普通医师(GP): 32%,ENT外科医生:16%,儿科医生:11%,过敏症专家:8%。1个月中,CPs(33